Background: The aspirin provocation test, considered to be the gold standard in the diagnosis of aspirin sensitivity, may be associated with severe adverse reactions; thus, alternative procedures with a higher safety profile are highly desirable. Although the cellular antigen stimulation test (CAST) has been proposed to be such an alternative, there is limited information about its clinical usefulness. Objective: It was the aim of our study to evaluate the clinical usefulness of CAST in the diagnosis of aspirin sensitivity. Material and Methods: Patients with aspirin-sensitive asthma and/or nasal polyps (n = 40), patients with aspirin-tolerant asthma and/or nasal polyps (n = 13) and healthy volunteers (n = 26) were included. A 2-day, single-blind placebo-controlled oral aspirin provocation test was performed. In vitro release of cysteinyl leukotrienes (Cys-LTs) by peripheral blood leukocytes was measured after stimulation with both stimulation buffer and lysine aspirin (2.5 mg/ml) by CAST. Results: Baseline Cys-LT levels were similar among the 3 groups. After lysine aspirin stimulation, the net increase in Cys-LTs was significantly higher in patients with aspirin sensitivity (median 91 pg/ml, interquartile range 22–206) compared with aspirin-tolerant patients (20 pg/ml, range 0–46) and healthy controls (23 pg/ml, range 0–71; p = 0.004). The assay had a sensitivity of 25%, a specificity of 92.3%, and positive and negative predictive values of 28.7 and 90.7%, respectively. Conclusion: Although the leukocytes of patients with aspirin sensitivity produce higher amounts of Cys-LTs as measured by CAST, the low sensitivity and predictive values limit the clinical usefulness of this test in the diagnosis of aspirin sensitivity.

1.
Stevenson DD: Adverse reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 1998;18:759–798.
2.
Everts B, Wahrborg P, Hedner T: COX-2 specific inhibitors – the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol 2000;19:331–343.
3.
Çelik G, Bavbek S, Mısırlıgil Z, Melli M: Release of cysteinyl leukotrienes with aspirin stimulation and effect of prostaglandin E2 on this release from peripheral blood leukocytes in aspirin-induced asthmatic patients. Clin Exp Allergy 2001;31:1615–1622.
4.
Daffern P, Muilenburg D, Hugli TE, Stevenson DD: Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 1999;104:559–564.
5.
Stevenson DD, Simon RA: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs; in Middleton E, Ellis EF, Yunginger JW, Reed CE, Adkinson NF, Busse WW (eds): Allergy: Principles and Practice, ed 5. St Louis, Mosby Company, 1998, pp 1225–1234.
6.
Stevenson DD, Szczeklik A: Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773–786.
7.
De Weck AL: Perspectives in allergy diagnosis. Int Arch Allergy Immunol 1992;99:252–256.
8.
Furukawa K, Tengler R, De Weck AL, Maly FE: Simplified sulfidoleukotriene ELISA using LTD4-conjugated phosphatase for the study of allergen-induced leukotriene generation by isolated mononuclear cells and diluted whole blood. J Invest Allergol Clin Immunol 1994;4:110–115.
9.
De Weck AL, Sanz ML: Cellular allergen stimulation test (CAST) 2003, a review. J Invest Allergol Clin Immunol 2004;14:253–273.
10.
Mewes T, Riechelmann H, Klimek L: Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy 1996;51:506–510.
11.
Pierzchalska M, Mastalerz L, Sanak M, Zalula M, Szczeklik A: A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leukocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy 2000;30:1785–1791.
12.
American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987;136:225–243.
13.
Sanz ML, Gamboa P, de Weck AL: A new combined test with flow cytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136:58–72.
14.
Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A: Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J 2000;15:863–869.
15.
Bavbek S, Çelik G, Ediger D, Mungan D, Sin B, Demirel YS, Mısırlıgil Z: Severity and associated risk factors in adult asthmatic patients in Turkey. Ann Allergy Asthma Immunol 2000;85:134–139.
16.
De Weck AL, Stadler BM, Urwyler A, Wehner HU, et al: Cellular allergen stimulation test (CAST). Allergy Clin Immunol News 1993;5:9–14.
17.
Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P: Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001;56:688–692.
18.
Czech W, Schopf E, Kapp A: Release of sulfidolekotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflam Res 1995;44:291–295.
19.
May A, Weber A, Gall H, Kaufmann R, Zollner TM: Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 1999;29:1402–1411.
20.
Abrahamsen O, Haas H, Schreiber J, Schlaak M: Differential mediator release from basophils of allergic and non-allergic asthmatic patients after stimulation with anti-IgE and C5a. Clin Exp Allergy 2001;31:368–378.
21.
Kubota Y, Imayama S, Toshitani A, Miyahara H, et al: Sulfidoleukotriene release test (CAST) in hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 1997;114:361–366.
22.
Brunner B, Eberlein-König B, Pryzbilla B: Histamine and sulfidoleukotriene release from peripheral blood leukocytes (PBL) of patients with anaphylactoid reactions provoked by acetylsalicylic acid (ASA). J Allergy Clin Immunol 1996;97:344.
23.
Wedi B, Kapp A: Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax 2000;55(suppl 2):S70–S71.
24.
Wolanczyk-Medrala A, Matolepszy J, Medrala W, Leibhart J, et al: CAST-ELISA test in diagnosis of aspirin idiosyncrasy in aspirin-induced asthma. Allergy 1995;50(suppl 26):246.
25.
Busse A, Czech W, Schöpf E, Simon JC: Der CAST-ELISA in der Diagnostik von pseudoallergischen Reaktionen gegen Nahrungsmitteladditiva und Azetylsalizylsäure. Allergologie 2000;23:110–115.
26.
de Weck AL, Gamboa PM, Esparza R, Sanz ML: Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). Curr Pharm Des 2006;12:3347–3358.
27.
Wedi B, Elsner J, Kapp A: In vitro diagnosis of pseudoallergic reactions – new aspects. Allergy Clin Immunol Int 1996;8:113–115.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.